451
Participants
Start Date
September 30, 2004
Primary Completion Date
July 31, 2008
Study Completion Date
July 31, 2008
lacosamide
Open-label treatment (two times per day) with film-coated tablets include 100mg/day, 200mg/day, 300mg/day, 400mg/day, 500mg/day, and 600mg/day throughout individual study period.
Anniston
Hoover
Huntsville
Northport
Tuscaloosa
Peoria
Phoenix
Tucson
Hot Springs
Jonesboro
Little Rock
Irvine
Los Angeles
San Diego
Santa Monica
Spring Valley
Tustin
Walnut Creek
Denver
Stratford
Newark
Wilmington
Bradenton
Clearwater
Fort Myers
New Port Richey
Ocala
Pembroke Pines
Pinellas Park
South Miami
St. Petersburg
Sunrise
Tallahassee
Marietta
Chicago
Elk Grove Village
North Chicago
Evansville
West Des Moines
Crestview Hills
Louisville
Madisonville
Paducah
Owings Mills
Towson
Brockton
Ann Arbor
St Louis
Great Falls
Omaha
Las Vegas
Lawrenceville
Voorhees Township
Albany
Mineola
White Plains
Charlotte
Greensboro
Greenville
Raleigh
Winston-Salem
Cincinnati
Toledo
Oklahoma City
Tulsa
Medford
Portland
Upland
Greer
Bristol
Nashville
Amarillo
Dallas
Fort Worth
Houston
Richardson
San Antonio
Bennington
Richmond
Salem
Virginia Beach
Spokane
Tacoma
Wenatchee
Lead Sponsor
UCB Pharma
INDUSTRY